Prof. Akash Chaurasiya
Prof. Akash Chaurasiya is an experienced researcher with work experience in R&D of various pharmaceutical companies like Dabur Research Foundation, Fresenius Kabi, Dr. Reddy’s Laboratories & Amneal Pharmaceuticals. During this tenure, he primarily worked on formulation development of complex products, i.e., liposomes, nano-suspensions, lyophilized products, etc., for regulated markets like US, EU, etc. Prof. Chaurasiya has played a pivotal role in developing, scaling up, and regulatory filing of these complex products and acted as co-inventor in several patents/applications. Prof. Chaurasiya also received the “Best Excellence and Innovation Award” and “Spot Recognition Award” during his tenure in Dr. Reddy’s lab.
Based on his interest in entrepreneurship, Prof. Chaurasiya has incubated a startup company, “Atreves Healthcare Pvt. Ltd.” in 2023, along with his PhD student. This company is aimed at developing innovative and affordable healthcare products. With this objective and intention, Atreves has been granted the prestigious and highly competitive Biotechnology Ignition grant (BIG) – 23, funded by BIRAC/DBT.
Prof. Chaurasiya is also acting as a Member of - Board of studies, Parenteral Drug Association (PDA), and contributing to setting up guidelines for training industrial professionals working in parenteral product manufacturing. During his extensive research experience, Prof. Chaurasiya was part of various innovative research projects, clearly depicted in the form of patents, research articles, book chapters, and national/international conference proceedings.
An Institute of Eminence
